How An Artist Becomes An Investor And Advisor To The World’s Greatest Technology Companies

Contenuto fornito da John Cumbers. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da John Cumbers o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

The SynBioBeta Podcast « »
How an artist becomes an investor and advisor to the world’s greatest technology companies - with D.A. Wallach

4+ y ago 52:28

MP3•Pagina principale dell'episodio

Serie archiviate ("Feed non attivo" status)

When? This feed was archived on October 13, 2022 16:21 (1+ y ago). Last successful fetch was on August 01, 2022 11:15 (1+ y ago)

Why? Feed non attivo status. I nostri server non sono riusciti a recuperare un feed valido per un periodo prolungato.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Today John Cumbers talks with D.A. Wallach, recording artist and emerging tech investor. John will be talking to D.A. about his journey from performing artist to investor in emerging tech, how his unique background informs his investment thesis, and what opportunities he’s most excited about in synthetic biology these days.

D.A. Wallach is a recording artist, songwriter, and investor. While an undergraduate at Harvard, he was discovered by Kanye West and Pharrell Williams. As a solo artist, D.A. is signed by Harvest Records, a subsidiary of Capitol Records, and he is the former artist-in-residence at Spotify, a company where he was an early investor. Beyond music, D.A. invests in and advises several start-up technology companies, including Synthego, Glypse Bio, Beam Therapeutics, SpaceX, Ripple. Forbes selected D.A. as one of its 30 Under 30, and Fast Company named him one of the 100 Most Creative People in Business. In 2015, he launched Inevitable Ventures, an investment partnership with multibillionaire Ron Burkle that supports radical entrepreneurs in areas including health care, life sciences, and financial technologies. He is also an advisor to The Dreamers Fund, a partnership with actor Will Smith.

Connect with D.A.: @dawallach

Connect with John: @johncumbers

Stay updated on the latest news in synthetic biology, check out our weekly newsletter and follow us on social media:

Twitter | LinkedIn | Facebook

Be sure you make it to SynBioBeta 2019 this October 1-3! Click here for more information.

17 episodi

#Trading #Business #Biotech #John Cumbers #Science #Natural Sciences